First of all, the leading technology:
1. With the in-depth development of infant milk powder in China, the milk powder industry has entered a new stage of specialization and quality. However, due to the obvious differences between Chinese and foreign breast milk ingredients, milk powder from different countries is based on their own breast milk ingredients research. Among them, Yili, as the earliest dairy enterprise that started breast milk research in China, led domestic brands to hit a new high market share with its infant formula brand, Ilikin.
2. Jinling Crown obtained the China patent authorization certificate of "Breast milk oligosaccharide for improving intestinal microenvironment health and its application" issued by China National Intellectual Property Administration.
3. Obtaining HMO patent this time is not only another mountain that Jinling has conquered in the field of breast milk research, but also an important step taken by the whole milk powder industry in the field of breast milk research in China.
Second, the formula is excellent:
1 As we all know, breast milk is the most ideal food for infants and the gold standard for infant formula research and development. There are about 1000 kinds of protein in breast milk, such as whey protein, which can promote the growth and development of infants. Active ingredients help babies resist bacterial viruses and enhance immunity, and the ingredients are quite complex, which means that every step of scientific research and innovation on breast milk nutrients is of great significance.
2. As the leading representative of milk powder in China, Yili continued to study HMO deeply and obtained HMO patent, which is the first invention patent in domestic dairy enterprises focusing on the health care function of breast milk oligosaccharides. It not only provides technical support for the formulation innovation of Jinling series products, but also is a key patent breakthrough in the research field of HMO health efficacy.